Literature DB >> 11731169

Antimicrobial susceptibility and plasmid analysis of Actinobacillus pleuropneumoniae isolated in Taiwan.

Chao Fu Chang1, Tung Mao Yeh, Chin Cheng Chou, Yung Fu Chang, Tai Sheng Chiang.   

Abstract

Sixty Actinobacillus pleuropneumoniae (App) strains from pigs in Taiwan were examined. Serotyping revealed that these belonged to serovars 1 (n=53), 2 (n=3), and 5 (n=4). Agar disk diffusion susceptibility testing of the isolates showed 55 (92%) were resistant to three or more antimicrobial agents. Six resistance patterns were observed. Ampicillin-chloramphenicol-flumequine-nalidixic acid-streptomycin-sulfonamide/trimethoprim-tetracycline was the most common multi-resistance pattern. Minimal inhibitory concentration of 14 antimicrobial agents was determined. The isolates were highly susceptible to ceftiofur and trimethoprim in vitro. Isolates were resistant to streptomycin, ampicillin, and nalidixic acid. All isolates were examined for the presence of plasmids using the alkaline lysis method. Forty three (72%) isolates had four plasmid bands with an approximate sizes of 3.5, 4.3, 5.8 and 6.0 kb; 12 (20%) had three bands at 3.5, 4.3 and 5.2 kb, and 5 (8%) had no plasmid bands. Antimicrobial resistance plasmids were detected in resistant strains of App. Three antimicrobial resistance plasmids were transformed into E. coli DH5 alpha. pTMY1 (4.3 kb) encoded a streptomycin kinase and a dihydropteroate synthase; pTMY2 (6.0 kb) encoded ROB-1 beta-lactamase and aminoglycoside 3'-phosphotransferase; pTMY3 (5.2 kb) encoded only ROB-1 beta-lactamase. The 4.3 kb plasmid was sequenced and consisted of 4242 bp with 42.9% GC content. The 4.3 kb plasmid DNA sequence was 98% homologous to a plasmid previously isolated from Pasteurella haemolytica.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11731169     DOI: 10.1016/s0378-1135(01)00459-x

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  7 in total

1.  Construction of an Actinobacillus pleuropneumoniae serotype 2 prototype live negative-marker vaccine.

Authors:  Walaiporn Tonpitak; Nina Baltes; Isabel Hennig-Pauka; Gerald F Gerlach
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

2.  Distribution of tetracycline resistance genes in Actinobacillus pleuropneumoniae isolates from Spain.

Authors:  Mónica Blanco; César B Gutiérrez-Martin; Elías F Rodríguez-Ferri; Marilyn C Roberts; Jesús Navas
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

3.  Novel blaROB-1-bearing plasmid conferring resistance to β-lactams in Haemophilus parasuis isolates from healthy weaning pigs.

Authors:  Javier Moleres; Alfonso Santos-López; Isidro Lázaro; Javier Labairu; Cristina Prat; Carmen Ardanuy; Bruno González-Zorn; Virginia Aragon; Junkal Garmendia
Journal:  Appl Environ Microbiol       Date:  2015-03-06       Impact factor: 4.792

4.  Identification of drug target candidates of the swine pathogen Actinobacillus pleuropneumoniae by construction of protein-protein interaction network.

Authors:  Siqi Li; Zhipeng Su; Chengjun Zhang; Zhuofei Xu; Xiaoping Chang; Jiawen Zhu; Ran Xiao; Lu Li; Rui Zhou
Journal:  Genes Genomics       Date:  2018-05-03       Impact factor: 1.839

5.  Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.

Authors:  Alvaro San Millan; Jose Antonio Escudero; Belen Gutierrez; Laura Hidalgo; Nerea Garcia; Montserrat Llagostera; Lucas Dominguez; Bruno Gonzalez-Zorn
Journal:  Antimicrob Agents Chemother       Date:  2009-06-15       Impact factor: 5.191

6.  Pharmacokinetic/Pharmacodynamic Relationships of Tulathromycin Against Actinobacillus pleuropneumoniae in a Porcine Tissue Cage Infection Model.

Authors:  Lihua Yao; Lan Yang; Yuzhou Ling; Yanzhe Wei; Xiangguang Shen; Huanzhong Ding
Journal:  Front Vet Sci       Date:  2022-03-28

7.  Occurrence of antimicrobial resistance among bacterial pathogens and indicator bacteria in pigs in different European countries from year 2002 - 2004: the ARBAO-II study.

Authors:  Rene S Hendriksen; Dik J Mevius; Andreas Schroeter; Christopher Teale; Eric Jouy; Patrick Butaye; Alessia Franco; Andra Utinane; Alice Amado; Miguel Moreno; Christina Greko; Katharina D C Stärk; Christian Berghold; Anna-Liisa Myllyniemi; Andrzej Hoszowski; Marianne Sunde; Frank M Aarestrup
Journal:  Acta Vet Scand       Date:  2008-06-13       Impact factor: 1.695

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.